[

177Lu chronic kidney disease dosimetry kidney failure prostate-specific membrane antigen radioligand therapy

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 08 03 2023
revised: 12 06 2023
pubmed: 25 8 2023
medline: 25 8 2023
entrez: 24 8 2023
Statut: ppublish

Résumé

We report the dosimetric evaluation of prostate-specific membrane antigen-based radioligand therapy (RLT) for metastatic prostate cancer in a patient with autosomal-dominant polycystic kidney disease.

Identifiants

DOI: 10.2967/jnumed.123.265577 PMID: 37620052
pubmed: 37620052
pii: jnumed.123.265577
doi: 10.2967/jnumed.123.265577
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1570-1573

Informations de copyright

© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Lorenzo Mercolli (L)

Department of Nuclear Medicine, Bern University Hospital, University of Bern, Bern, Switzerland; lorenzo.mercolli@insel.ch.

Clemens Mingels (C)

Department of Nuclear Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.

Giulia Manzini (G)

Department of Nuclear Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.

Paul Cumming (P)

Department of Nuclear Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.
School of Psychology and Counselling, Queensland University of Technology, Brisbane, Queensland, Australia; and.

Konstantinos Zeimpekis (K)

Department of Nuclear Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.

Song Xue (S)

Department of Nuclear Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.

Ian Alberts (I)

Department of Nuclear Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.

Dominik Uehlinger (D)

Department of Nephrology and Hypertension, Bern University Hospital, University of Bern, Bern, Switzerland.

Axel Rominger (A)

Department of Nuclear Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.

Kuangyu Shi (K)

Department of Nuclear Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.

Ali Afshar-Oromieh (A)

Department of Nuclear Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.

Classifications MeSH